News

EastGroup Properties Reports on Leasing Trends and Upcoming Events

EastGroup Properties Reports on Leasing Trends and Upcoming Events

Latest Updates from EastGroup Properties

EastGroup Properties, Inc. (NYSE: EGP) has recently shared exciting updates regarding its business activities. The company's portfolio showcases a strong leasing performance, achieving a leasing rate of 97.1% and an occupancy rate of 95.8%. In the ongoing 2025 fiscal year, EastGroup has signed a remarkable 1,438,000 square feet in new and renewed leases, with rental rate increases averaging 45% on a straight-line basis and 30.9% on a cash basis.

Notable Lease Agreements and Developments

As of the latest reporting, the company has entered into important lease agreements following earlier announcements. In Charlotte, Conn's Inc. terminated its lease for 300,000 square feet as part of its Chapter 11 bankruptcy proceedings. In a proactive measure, EastGroup successfully leased this entire space for a period of 7.5 years, beginning on March 31, 2025, with a rental increase of around 20%.

Additionally, the company has executed three leases on development properties totaling approximately 151,000 square feet since its February earnings release. Such initiatives highlight EastGroup’s strategic commitment to expanding its footprint in key markets.

Forward Equity Sale Agreements

In terms of financial activities, EastGroup has entered into forward equity sale agreements for 611,956 shares of common stock at an initial weighted average forward price of $180.27 per share, expecting gross proceeds of approximately $110 million. It's important to note that proceeds will be realized only when forward purchasers finalize their share distributions. The company recently settled prior forward equity agreements, issuing 214,138 shares of common stock for net proceeds of about $37 million.

Upcoming Conference Participation

Management will present at the Citi 2025 30th Annual Global Property CEO Conference, scheduled for March 4, 2025, at 11:00 a.m. Eastern Time. Investors can expect live discussions from EastGroup executives, covering transaction activities, the leasing environment, market trends, and other important business updates. Presentation materials related to EastGroup’s discussions will be available on the investor relations section of their website.

CEO's Comments on Performance

Marshall Loeb, the CEO of EastGroup, expressed satisfaction with the company's current leasing trends and occupancy levels, stating, "We see positive momentum as we begin 2025. The occupancy is aligning with our forecasts, and we anticipate fruitful conversations with stakeholders at the upcoming Citi conference. We are always here to address inquiries and engage with our community."

About EastGroup Properties, Inc.

EastGroup Properties is a self-administered equity real estate investment trust (REIT) operating within the S&P Mid-Cap 400 and Russell 2000 Indexes. With a proactive approach, the company focuses on the acquisition, development, and management of industrial properties located in prominent Sunbelt markets across the United States, particularly emphasizing regions like Texas, Florida, California, Arizona, and North Carolina. EastGroup aims to provide exceptional business distribution space designed for the needs of location-sensitive tenants, predominantly focusing on facilities between 20,000 to 100,000 square feet. Currently, EastGroup's portfolio spans approximately 63.1 million square feet, which includes ongoing development projects and value-added acquisitions.

Frequently Asked Questions

What recent leasing rates did EastGroup Properties report?

EastGroup Properties reported average rental rate increases of 45% on a straight-line basis and 30.9% on a cash basis.

What significant lease agreement did EastGroup secure recently?

EastGroup secured a 7.5-year lease for a 300,000 square feet space previously held by Conn's Inc., with a rental increase of roughly 20%.

How many shares did EastGroup enter into forward equity sale agreements for?

EastGroup entered into forward equity sale agreements for 611,956 shares of common stock.

When will EastGroup present at the Citi conference?

EastGroup's management is set to present at the Citi 2025 30th Annual Global Property CEO Conference on March 4, 2025, at 11:00 a.m. Eastern Time.

What is EastGroup's focus as a REIT?

EastGroup focuses on the acquisition, development, and management of quality industrial properties in prime markets, aiming to maximize shareholder value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Eco Wave Power Expands Wave Energy Project in Europe

Updated Category News Views 229

Eco Wave Power Initiates Key Infrastructure Enhancements Eco Wave Power Global AB (publ) (NASDAQ: WAVE) is excited to unveil plans for crucial upgrades at its groundbreaking wave energy project. This groundbreaking initiative is set to harness ocean wave energy to produce clean electricity efficiently. Eco Wave Power, recognized as a leading company in onshore wave energy...

Continue Reading
Key Managerial Transactions Reported by Danske Bank A/S

Updated Category News Views 162

Recent Mandatory Transaction Notifications by Danske Bank A/S Danske Bank A/S is committed to transparency in financial transactions involving its managerial personnel. This communication signifies the bank's adherence to the EU Market Abuse Regulation and the requirements set by the Danish Financial Supervisory Authority (FSA) and Nasdaq Copenhagen. Understanding...

Continue Reading
Strategic Insights into Symbotic's Options Market Activity

Updated Category News Views 187

Overview of Options Activity for Symbotic Recently, significant investors have demonstrated a notably bearish outlook on Symbotic. This trend has been evidenced by the options activity surrounding the company's stock, symbolized by SYM. The strong presence of whales entering the market indicates a shift in investor sentiment, with nuances that are crucial for...

Continue Reading
South Coast AQMD Takes Action on Oil Facilities During Violations

Updated Category News Views 267

South Coast AQMD Addresses Oil Site Violations In a determined effort to safeguard public health and air quality, the South Coast Air Quality Management District (South Coast AQMD) has recently taken enforcement action against three oil and gas facilities in Los Angeles. These actions were prompted by public complaints and confirmed violations of air quality regulations,...

Continue Reading
BAM UK & Ireland and LoadSpring Solutions Innovate Project Management

Updated Category News Views 199

BAM UK & Ireland and LoadSpring Solutions Innovate Project Management BAM UK & Ireland, a prominent name in the construction and engineering sector, has taken a bold step forward by partnering with LoadSpring Solutions. This collaboration aims to revolutionize project management through an innovative solution known as LoadSpring INSIGHTS™. This groundbreaking platform...

Continue Reading